title: Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.
abstract: The survival experience of 261 patients with cancer of the cervix registered by the Kampala population-based cancer registry, Uganda, in 1995-1997, is described. Vital status of the subjects was established by active methods including a search of hospital records and house visits. Of the 261 cases, 82 (31.4%) were dead and 105 (40.2%) were alive at the closing date of 31 December 1999; the remaining 74 cases (28.4%) were lost during the follow-up period. Overall observed and relative survival at 3 years was 52.4 and 59.9%, respectively. Of these cases, one-quarter (63) had been treated in the radiotherapy department. These cases had better survival (82.6%) than nontreated patients (78.5%) after 1 year of follow-up, but there was no difference at 3 years. HIV status was not significantly related to prognosis. Stage is an important determinant of survival: cases with distant metastasis had a risk of death some three times that of patients with localised disease. Early detection and prompt treatment should improve overall survival from cervix cancer, in the African context.
authors.affiliation: Kampala Cancer Registry, Department of Pathology, Makerere University Medical School, Kampala, Uganda. cancer-reg@infocom.co.ug
authors.forename: H
authors.initials: H
authors.lastname: Wabinga
authors.forename: A V
authors.initials: AV
authors.lastname: Ramanakumar
authors.forename: C
authors.initials: C
authors.lastname: Banura
authors.forename: A
authors.initials: A
authors.lastname: Luwaga
authors.forename: S
authors.initials: S
authors.lastname: Nambooze
authors.forename: D M
authors.initials: DM
authors.lastname: Parkin
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D013534:Survival; D014454:Uganda; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000532:radiotherapy